SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is surging after reporting strong Q3 earnings driven by booming cloud and AI infrastructure demand and a substantial increase in remaining performance obligations, notably from a major OpenAI deal. This performance is boosting bullish sentiment and prompting analyst upgrades, though some traders remain cautious about potential post-earnings profit-taking.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSS Inc. is trending after reporting strong Q4 and full-year results that significantly beat expectations, driven by its AI rack integration business and an extended Dell partnership, leading to widespread community discussion about a potential short squeeze and its pivotal role in the ongoing AI infrastructure buildout.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Papa John's is trending due to reports of a renewed takeover bid from a Qatari-backed investment fund, Irth Capital Management, with the community actively debating the adequacy of the rumored $47 per share offer against previous takeover speculations and the potential for a higher acquisition price to take the pizza chain private.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to its imminent uplisting to the NYSE and CEO Gary Evans' high-profile media appearances highlighting substantial government funding for domestic antimony production and significant tungsten reserves. The community is actively discussing the company's critical role in national defense and AI given China's supply restrictions, contrasting long-term bullish sentiment with short-term "sell the news" volatility.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is seeing significant momentum after a federal appeals court denied environmental groups' emergency request to halt the restart of its Santa Ynez oil pipeline, fueling community speculation of a major short squeeze given the high short interest and anticipation of increased domestic oil production.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to escalating tensions between its founder and the board over weak governance and strategic missteps, alongside recent brand concerns regarding "sheer" new leggings. The community is expressing widespread frustration over the stock's consistent decline and slow management action, debating if current valuations present a buying opportunity.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following Nvidia's $2 billion investment and strategic partnership to scale its AI cloud capacity, establishing it as a key player in the burgeoning AI infrastructure market. The community sees this as a strong validation, anticipating a short squeeze and upward movement due to reduced dilution fears and comparisons favoring Nebius's financial structure.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending due to high anticipation for its upcoming earnings report and its recent AIUC-1 certification validating secure enterprise AI agent deployment. This fuels a polarized community debate between those expecting a significant short squeeze and fundamental strength in Agentic AI, and bears concerned about competition and valuation.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as the market reacts to the resolution of its legal challenges with Novo Nordisk, de-risking the business and opening doors for new growth in areas like GLP-1s and peptides. The community is actively discussing a massive short squeeze, celebrating strong bullish momentum and anticipating the stock's return to much higher price levels as trapped shorts are forced to cover.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

FRMI is trending due to the approval of its critical Clean Air Permit and a $500 million equipment loan, igniting strong community discussion and expectations for an imminent major tenant announcement. The company's large-scale AI data center power campus is seen as a key solution addressing surging industry demand for energy infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$COGT  
 
Cogent announces additional results from SUMMIT trial of bezuclastinib 
 
Cogent Biosciences announced additional clinical results from the SUMMIT trial with bezuclastinib in patients with NonAdvanced Systemic Mastocytosis at the American Academy of Allergy Asthma &amp; Immunology, AAAAI, Annual Meeting. As previously reported, bezuclastinib demonstrated clinically meaningful and highly statistically significant improvements across the primary and all key secondary endpoints. Treatment with bezuclastinib resulted in rapid, durable, statistically significant symptomatic improvements which continued to deepen out to 48 weeks: Patients on bezuclastinib reported a -32.0 point mean change in TSS, representing a 56% relative improvement in TSS from baseline; 86% of patients achieved a clinically meaningful threshold of 30% improvement in symptoms; 99% of patients had at least 50% reduction in serum tryptase, with 83.3% of patients achieving normalization.  
 
Bezuclastinib demonstrates strong evidence of disease modification in NonAdvSM patients based on: Significant correlation shown between serum tryptase reduction and symptomatic improvement as measured by TSS, all symptom domains, and 10/11 individual symptoms; Clinically meaningful improvements in bone mineral density at week 24 for patients treated with bezuclastinib, regardless of baseline bone health severity; 50% of patients reported a dose reduction and/or discontinuation of best supportive care medicines during the treatment period at week 48.

Randy

Claudiu Simon Ciobanu

Devis

StockTwits Web

Cogent Biosciences Inc

  
 
Cogent announces additional results from SUMMIT trial of bezuclastinib 
 
Cogent Biosciences announced additional clinical results from the SUMMIT trial with bezuclastinib in patients with NonAdvanced Systemic Mastocytosis at the American Academy of Allergy Asthma & Immunology, AAAAI, Annual Meeting. As previously reported, bezuclastinib demonstrated clinically meaningful and highly statistically significant improvements across the primary and all key secondary endpoints. Treatment with bezuclastinib resulted in rapid, durable, statistically significant symptomatic improvements which continued to deepen out to 48 weeks: Patients on bezuclastinib reported a -32.0 point mean change in TSS, representing a 56% relative improvement in TSS from baseline; 86% of patients achieved a clinically meaningful threshold of 30% improvement in symptoms; 99% of patients had at least 50% reduction in serum tryptase, with 83.3% of patients achieving normalization.  
 
Bezuclastinib demonstrates strong evidence of disease modification in NonAdvSM patients based on: Significant correlation shown between serum tryptase reduction and symptomatic improvement as measured by TSS, all symptom domains, and 10/11 individual symptoms; Clinically meaningful improvements in bone mineral density at week 24 for patients treated with bezuclastinib, regardless of baseline bone health severity; 50% of patients reported a dose reduction and/or discontinuation of best supportive care medicines during the treatment period at week 48.

Microsoft Corp

iShares Russell 2000 ETF

iShares 20+ Year Treasury Bond ETF

Alphabet Inc Class A

DonCorleone77

@DonCorleone77 my man! Ur here too. Always happy when i come along one of ur posts in the wild. Keep on keep on

StockTwits For Android 

 my man! Ur here too. Always happy when i come along one of ur posts in the wild. Keep on keep on